Page last updated: 2024-10-27

fenofibrate and Lymphoma, B-Cell

fenofibrate has been researched along with Lymphoma, B-Cell in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, J1
Das, SK1
Jha, P1
Al Zoughbi, W1
Schauer, S1
Claudel, T1
Sexl, V1
Vesely, P1
Birner-Gruenberger, R1
Kratky, D1
Trauner, M1
Hoefler, G1

Other Studies

1 other study available for fenofibrate and Lymphoma, B-Cell

ArticleYear
The PPARĪ± agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism.
    Biochimica et biophysica acta, 2013, Volume: 1831, Issue:10

    Topics: Animals; B-Lymphocytes; Cell Proliferation; Fatty Acids, Nonesterified; Fenofibrate; Hypolipidemic A

2013